Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating coronary disease

A coronary heart disease and drug technology, applied in the field of drugs for the treatment of coronary heart disease, can solve the problems of myocardial blood supply recurrence, blockage, narrowing of blood vessels, etc., and achieve the effects of reducing blood viscosity, dissolving thrombus, and resisting arteriosclerosis

Inactive Publication Date: 2009-01-07
卢超忠
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it cannot solve the problem of re-precipitation of lipids and other garbage in blood vessels to form new plaques from the source, resulting in re-narrowing and blockage of blood vessels, poor blood supply to the myocardium, and recurrence of old diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating coronary disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] A kind of medicine for the treatment of coronary heart disease of embodiment 1 is the oral liquid preparation that is made of following original drug:

[0035] Angelica 12g, Astragalus 15g, Chuanxiong 14g, Salvia miltiorrhiza 15g, Bupleurum 12g, Nuzhenzi 15g, Scrophulariae 13g, Eucommia 13g, Aloe 5g, Changshan 6g, Licorice 15g.

[0036] The above is the raw material composition of a pair of medicaments (when mass production, each component will be expanded in proportion), soak it in water for 1.5 hours according to the volume ratio of medicine: water of 1:2, add an appropriate amount of water to decoct for 1 hour, and consider Remove the medicinal residues to obtain 150 milliliters of medicinal liquid, which can be sterilized and packed. Take it three times in the morning, middle and evening, 50 ml each time, and one month is a course of treatment.

Embodiment 2

[0037] Embodiment 2 A kind of medicine for the treatment of coronary heart disease, is the oral liquid preparation that is made of following original medicine:

[0038] Angelica 10g, Astragalus 16g, Chuanxiong 10g, Salvia miltiorrhiza 13g, Bupleurum 15g, Nuzhenzi 12g, Scrophulariaceae 16g, Eucommia 15g, Aloe 6g, Changshan 5g, Shouwu 10g, Rehmannia 15g, Ophiopogon japonicus 14g, Polygonatum 15g, Schisandra 15g , wolfberry fruit 20g, licorice 12g.

[0039] The preparation and administration method are the same as in Example 1.

Embodiment 3

[0040] Embodiment 3 is a kind of medicine for the treatment of coronary heart disease, is the oral liquid preparation that is made of following original drug:

[0041] Angelica 15g, Astragalus 10g, Chuanxiong 16g, Salvia 10g, Bupleurum 10g, Nuzhenzi 17g, Scrophulariae 15g, Eucommia 10g, Aloe 4g, Changshan 7g, Guizhi 9g, Epimedium 10g, Licorice 18g.

[0042] The preparation and administration method are the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for curing coronary heart diseases. The medicament is a preparation which comprises the following crude drugs by the weight part: 8 to 16 parts of Chinese angelica root, 9 to 19 parts of hoantchy root, 9 to 18 parts of ligusticum wallichii, 9 to 18 parts of red-rooted salvia root, 8 to 16 parts of Chinese thorowax root, 9 to 18 parts of glossy privet fruit, 9 to 18 parts of scrophulariaceae canaria, 9 to 18 parts of eucommia bark, 3 to 6 parts of aloe and 4 to 8 parts of antifebrile dichroa. The formula of the medicament focuses on the regulation of kidney functions, and at the same time, attaches importance to the coordination of functions of internal organs, such as the kidney, the heart, the liver, the spleen, etc. The medicament can not only reduce blood lipid, resist coagulation, reduce blood viscidity and dissolve internal clot, but also improve the functions of blood vessel endothelium. Furthermore, the medicament can remove vasospasm, resist arteriosclerosis and stabilize vulnerable plaque, and have double curative effects on blood diseases and vascular diseases, thereby effectively curing the cardiovascular system diseases.

Description

technical field [0001] The invention relates to a medicine for treating coronary heart disease, in particular to a medicine for treating coronary heart disease which is made from plant Chinese herbal medicine. Background technique [0002] According to the statistics of the World Health Organization (WHO), in the world, one out of every three people dies from cardiovascular and cerebrovascular diseases. Now nearly 18 million people die from cardiovascular and cerebrovascular diseases every year. Cardiovascular and cerebrovascular diseases have a high incidence rate, high disability rate, high recurrence rate, and high mortality rate, and have become the number one killer threatening human health. Coronary heart disease is the abbreviation of coronary atherosclerotic heart disease. It refers to severe atherosclerosis or spasm of coronary arteries, the blood vessels that supply nutrients to the heart. Stenosis or blockage of coronary arteries, and occlusion of the lumen caus...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61K36/8969A61K36/9066A61K9/08A61K9/10A61K9/14A61K9/20A61K9/48A61P9/10A61K35/02
Inventor 卢超忠
Owner 卢超忠
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com